{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T09:58:19Z","timestamp":1792749499168,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"vor","delay-in-days":4437,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.fertnstert.2010.12.027","type":"journal-article","created":{"date-parts":[[2011,1,18]],"date-time":"2011-01-18T04:13:03Z","timestamp":1295323983000},"page":"1073-1079.e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":389,"title":["Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis"],"prefix":"10.1016","volume":"95","author":[{"given":"Robert A.","family":"Wild","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfredi","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheri","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Carmina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2010.12.027_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/8.3.231","article-title":"Long-term health consequences of PCOS","volume":"8","author":"Wild","year":"2002","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1067\/mhj.2001.114974","article-title":"INTER-HEART: a global study of risk factors for acute myocardial infarction","volume":"141","author":"Ounpuu","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib3","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1210\/jc.2008-0222","article-title":"Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline","volume":"93","author":"Rosenzweig","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib4","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1093\/ajcn\/78.5.928","article-title":"Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration","volume":"78","author":"Kahn","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib5","first-page":"35","article-title":"High cholesterol and triglyceride values in Swedish males and females: increased risk of fatal myocardial infarction. First report from the AMORIS (Apolipoprotein Related Mortality Risk) study","volume":"4","author":"Walldius","year":"1992","journal-title":"Blood Press Suppl"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib6","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0140-6736(01)07098-2","article-title":"High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study","volume":"358","author":"Walldius","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib7","first-page":"124","article-title":"Lipids, risk factors and ischemic heart disease","author":"Castelli","year":"1996","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib8","doi-asserted-by":"crossref","first-page":"3H","DOI":"10.1016\/0002-9149(92)91083-G","article-title":"Epidemiology of triglycerides: a view from Framingham","volume":"70","author":"Castelli","year":"1992","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib9","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1161\/01.CIR.96.7.2468","article-title":"Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association Writing Group","volume":"96","author":"Mosca","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib10","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1210\/jcem-61-5-946","article-title":"Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome","volume":"61","author":"Wild","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 1","key":"10.1016\/j.fertnstert.2010.12.027_bib11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/13697130903003842","article-title":"Cardiovascular risk and events in polycystic ovary syndrome","volume":"12","author":"Carmina","year":"2009","journal-title":"Climacteric"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib12","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2004-1045","article-title":"Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome","volume":"90","author":"Apridonidze","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/01.AOG.0000167408.30893.6b","article-title":"Screening women with polycystic ovary syndrome for metabolic syndrome","volume":"106","author":"Dokras","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"6","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib15","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0015-0282(99)00401-X","article-title":"Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors","volume":"72","author":"Legro","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0002-9378(11)90605-X","article-title":"Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance","volume":"166","author":"Wild","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib18","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","article-title":"Coronary heart disease risk factors in women with polycystic ovary syndrome","volume":"15","author":"Talbott","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3109\/09513599609012817","article-title":"Elevated low-density lipoprotein-cholesterol in women with polycystic ovary syndrome","volume":"10","author":"von Eckardstein","year":"1996","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib20","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1093\/oxfordjournals.humrep.a019505","article-title":"Dyslipidemia in polycystic ovarian syndrome: different groups, different aetiologies?","volume":"11","author":"Meirow","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib21","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/humrep\/14.8.1949","article-title":"Alterations in cardiac flow parameters in patients with polycystic ovarian syndrome","volume":"14","author":"Tiras","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib23","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/jcem.87.8.8716","article-title":"Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state","volume":"87","author":"Yildiz","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.0001-6349.2005.00678.x","article-title":"Impaired uterine perfusion associated with metabolic disorders in women with polycystic ovary syndrome","volume":"84","author":"Chekir","year":"2005","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib25","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1210\/jc.2004-2363","article-title":"Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome","volume":"90","author":"Vryonidou","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib26","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1210\/jc.2004-2279","article-title":"Phenotypic variation in hyperandrogenic women influences the findings of abnormal metabolic and cardiovascular risk parameters","volume":"90","author":"Carmina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1210\/jc.2006-1705","article-title":"Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome","volume":"92","author":"Berneis","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1055\/s-2007-967093","article-title":"Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome","volume":"115","author":"Hahn","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jc.2007-1756","article-title":"A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study","volume":"93","author":"Valkenburg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1742-1241.2008.01897.x","article-title":"Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome","volume":"63","author":"Rizzo","year":"2009","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10815-008-9280-8","article-title":"Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in western Anatolia, Turkey","volume":"26","author":"Cetinkalp","year":"2009","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib32","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1575-0922(09)70553-4","article-title":"[Relationship between the triglyceride\/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome]","volume":"56","author":"Roa Barrios","year":"2009","journal-title":"Endocrinol Nutr"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib33","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/humrep\/dep121","article-title":"Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype","volume":"24","author":"Rizzo","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1155\/2009\/465203","article-title":"Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index","volume":"26","author":"Samy","year":"2009","journal-title":"Dis Markers"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib35","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/AOG.0b013e3181bd12cb","article-title":"ACOG practice bulletin no. 108: polycystic ovary syndrome","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib36","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a position statement by the Androgen Excess & Polycystic Ovary Syndrome (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib37","first-page":"3389","article-title":"Altered composition of high density lipoproteins in women with the polycystic ovary syndrome","volume":"82","author":"Rajkhowa","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib38","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2003-030334","article-title":"Prevalence and predictors of coronary artery calcification in women with polycystic ovary syndrome","volume":"88","author":"Christian","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib39","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0015-0282(03)00265-6","article-title":"Relation of intra-abdominal fat distribution to metabolic disorders in nonobese patients with polycystic ovary syndrome","volume":"79","author":"Yildirim","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1139\/Y08-014","article-title":"Lipid and lipoprotein profile in women with polycystic ovary syndrome","volume":"86","author":"Macut","year":"2008","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/09513590802549874","article-title":"Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome","volume":"25","author":"Oral","year":"2009","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib42","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF03345790","article-title":"Novel inflammatory markers in overweight women with and without polycystic ovary syndrome and following pharmacological intervention","volume":"33","author":"Moran","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib43","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib44","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1093\/humrep\/deg440","article-title":"Difference in body weight between American and Italian women with polycystic ovary syndrome: influence of the diet","volume":"11","author":"Carmina","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF03345564","article-title":"Differences in dyslipidemia between American and Italian women with polycystic ovary syndrome","volume":"31","author":"Essah","year":"2008","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib46","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1210\/jc.2004-0744","article-title":"Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study","volume":"90","author":"Mudali","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.12.027_bib47","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/aje\/154.6.489","article-title":"Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation","volume":"154","author":"Liu","year":"2001","journal-title":"Am J Epidemiol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028210029699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028210029699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:46:47Z","timestamp":1758008807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028210029699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0015028210029699"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2010.12.027","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2010.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}